KEQU logo

KEQU
Kewaunee Scientific Corporation

164
Mkt Cap
$114.75M
Volume
19,671.00
52W High
$71.33
52W Low
$30.33
PE Ratio
9.67
KEQU Fundamentals
Price
$38.79
Prev Close
$40.00
Open
$38.41
50D MA
$41.39
Beta
0.70
Avg. Volume
12,827.21
EPS (Annual)
$3.83
P/B
1.71
Rev/Employee
$194,085.55
Loading...
Loading...
News
all
press releases
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026 PR Newswire STATESVILLE, N.C., Dec. 10, 2025...
PR Newswire·20h ago
News Placeholder
More News
News Placeholder
Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc.
Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc. Kewaunee Scientific Announces Successful Debt Refinancing...
PR Newswire·7d ago
News Placeholder
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026 Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026 PR Newswire STATESVILLE, N.C., Nov. 26, 2025...
PR Newswire·15d ago
News Placeholder
The Zacks Analyst Blog Highlights NVIDIA, Roche, Lam Research, Tredegar and Kewaunee Scientific
NVIDIA, Roche, and Lam Research lead this week's top Zacks research picks, while Tredegar and Kewaunee Scientific highlight strong niche and microcap opportunities.
Zacks·2mo ago
News Placeholder
Top Stock Reports for NVIDIA, Roche & Lam Research
NVIDIA, Roche, and Lam Research lead today's top Zacks reports, showcasing standout growth drivers and sector-specific strengths.
Zacks·2mo ago
News Placeholder
Kewaunee Scientific Q1 Earnings Rise Y/Y, Stock Slides 19%
KEQU's Q1 revenues and EPS grow y/y, aided by Nu Aire, yet shares drop 19% as investors weigh uneven project timelines and rising costs.
Zacks·3mo ago
News Placeholder
The Zacks Analyst Blog Highlights Lowe's, Bristol-Myers Squibb, Marvell Technology and Kewaunee Scientific
Zacks spotlights Lowe's, Bristol Myers, Marvell, and Kewaunee Scientific as earnings, strategy, and acquisitions shape growth outlooks.
Zacks·4mo ago
News Placeholder
Top Research Reports for Lowe's, Bristol-Myers & Marvell Technology
Lowe's leans on Pro-focused strategy and AI-powered retail tools, Bristol-Myers banks on new drug launches to offset legacy declines, and Marvell rides AI-driven data center growth despite consumer softness.
Zacks·4mo ago
News Placeholder
Kewaunee Upgraded to Outperform on Nu Aire Synergies, Backlog
KEQU earns an upgrade to "Outperform" as Nu Aire integration drives sales growth, margins expand and a record backlog boosts visibility, offsetting tariff risks with proactive inventory strategies.
Zacks·4mo ago
News Placeholder
The Zacks Analyst Blog Highlights NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific and Natural Health Trends
NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific, and Natural Health Trends show strong market momentum, each leveraging unique growth drivers despite sector-specific challenges.
Zacks·4mo ago

Latest KEQU News

View

Advertisement|Remove ads.

Advertisement|Remove ads.